A labeled metabolite of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity.
Please note that users have reported separation of this compound and dehydroaripiprazole under normal-phase and reverse-phase HPLC conditions in a manner similar to that described in: Davis et al., Journal of Chromatography A, 731, (1996), 351-354 and Baweja, Journal of Liquid Chromatography, 9(12), (1986), 2609-2621.
Melting Point:123-125°C
Solubility:Methanol
Method for Determining Identity:‘H NMR Spectroscopic and Mass Spectrometric Analysis.
TLC Conditions:SiO2; Dichloromethane: Methanol: NH4OH; 9.2ml; 0.8ml: 4 drops; Visualized with UV and AMCS; Single spot; Rf=0.4.
Chloride Content:7.2%
Relative intensity of 7% D7, 0.2% D6, 0.004% D5, 0.0004% D4 and no D3, D2, D1 and D0 were detected.
Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
